The Moon is three days away. Mars, at closest approach, is about six months. Those numbers exist in most people's mental model of space travel alongside rockets and spacesuits and the general sense that getting there is hard but conceivable — something humans have done, or will do soon.
Alpha Centauri, the nearest star system to our own, is 4.37 light-years away. Voyager 1, launched in 1977 and the only human-made object to have left the solar system, travels at roughly 17 kilometers per second. At that speed, it would take approximately 73,000 years to reach Alpha Centauri. Nobody alive today would arrive. Nobody's great-great-grandchildren would arrive. The nearest star is not far in the way that Australia is far. It is far in a way that redefines what "journey" means. Everything worth visiting beyond our solar system — other stars, potentially habitable worlds — sits behind distances that dwarf recorded human history.
Aging is necessary for that journey. It is not sufficient. A body that lasts long enough still has to survive centuries of galactic cosmic rays. Longevity and continuous DNA repair are both required; rockets alone close neither gap.
The math
The most optimistic propulsion concepts being seriously discussed today — nuclear pulse propulsion, laser sail — could theoretically accelerate a spacecraft to roughly 5% the speed of light. Breakthrough Starshot, an active research initiative, targets 20% c for a gram-scale probe; a crewed ship is orders of magnitude heavier, must decelerate at the destination, and has to carry life support the whole way. Those constraints pull crewed speeds back toward the lower single-digit percentages of c. 5% c is optimistic but not fantastical.
At 5% c, the arithmetic looks like this: Alpha Centauri takes approximately 87 years to reach. Barnard's Star, about 6 light-years out, takes around 120 years. Tau Ceti, one of the more promising nearby candidates for a potentially habitable world, is nearly 12 light-years away — about 240 years at this speed.
A few assumptions are baked into those numbers that are worth naming.
First, that the traveler is a single person, not a generation ship. The generation ship is often raised as the obvious alternative: send enough people, let them reproduce, the descendants arrive. But a generation ship doesn't sidestep the complexity of this problem — it trades one kind for another. To sustain human life across centuries in deep space, you need closed-loop food production, a functioning ecosystem, social structures that maintain coherent purpose across generations that never chose to make the journey, and governance that survives the death of everyone who did.
Modest improvements to human healthspan — 200-year generations rather than 80-year ones — reduce the number of handoffs but don't eliminate any of that. You still need the farm. A single traveler with extreme longevity and hibernation trades all of that for one hard biological problem.
Second, that hibernation exists as a future capability. Sleeping through most of the trip compresses what the traveler experiences; it does not stop aging or radiation damage. The body still has to survive intact across the full elapsed duration.
Third, that "making the journey" means arriving with enough life and health remaining to be useful — not just technically alive on landing.
With those assumptions in place: a round trip to the nearest star system requires on the order of 200 years of healthy life. A handful of Tau Ceti–class targets, round-trip, pushes the requirement toward roughly a thousand years of sustained biological integrity. Those numbers follow from the distances and the propulsion speeds above — not from a wish list.
The radiation problem
Deep space is not empty. It is saturated with galactic cosmic rays — high-energy particles produced by supernovae and other stellar events that travel at near-light speeds and pass through conventional shielding as if it weren't there. On Earth, the atmosphere absorbs most of this radiation. In deep space, on a journey of centuries, the cumulative DNA damage from cosmic ray exposure is incompatible with biological survival as we currently understand it.
More shielding means more mass, and mass is the primary enemy of the propulsion speeds this journey requires. There are physical limits to how much shielding a spacecraft can carry. At interstellar distances, those limits are not enough. Shielding can reduce exposure. It cannot eliminate it.
Current human biology can repair ordinary levels of DNA damage. It is not designed for centuries of deep-space cosmic ray exposure. That is a second biological requirement, distinct from longevity but related to it: a body capable of continuously detecting and repairing radiation-induced DNA damage at the rate deep space demands. Unlike shielding, this solution doesn't add mass. It travels with you.
The prerequisite
The biological requirements for surviving a deep-space journey don't exist yet. A body that lives for a thousand years and continuously repairs radiation damage across centuries of exposure is not something medicine knows how to produce. It will need to be solved before any single human can make a journey of this kind.
This is not a gap that better mission planning closes. It is not a problem that more capable rockets make smaller. It is a hard prerequisite: a thing that must be true before the other thing can happen.
Longevity research, and specifically the problem of sustained DNA repair under chronic radiation exposure, is a space problem whether or not it is being framed as one.
The bottleneck
We have kept these conversations entirely separate. One community works on propulsion, orbital mechanics, and life support. Another works on cellular repair, senescence, and healthspan extension. They publish in different journals and compete for different funding. Nobody is standing at the intersection pointing out the dependency.
The rocket is not the bottleneck.
We will not send a human to another star system in a body that lasts eighty years. The rockets matter. The propulsion matters. But no engineering breakthrough closes that gap on its own. A biological one is also required — and we have not yet decided to treat it that way.